Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.

Gallagher KE, Kelly H, Cocks N, Dixon S, Mounier-Jack S, Howard N, Watson-Jones D.

Papillomavirus Res 2018;6:33-40.

PMID:30352297

PMCID:PMC6218645

DOI:10.1016/j.pvr.2018.10.004

The validity of an area-based method to estimate the size of hard-to-reach populations using satellite images: the example of fishing populations of Lake Victoria.

Nash S, Tittle V, Abaasa A, Sanya R, Hansen C, Grosskurth H, Kapiga S, Grundy C on behalf of the Lake Victoria Consortium for Health Research.

Emerg Themes Epidemiol 2018;15:11.

PMID:30123310

PMCID:PMC6090724

DOI:10.1186/s12982-018-0079-5

Evaluating the impact of an intervention to increase uptake of modern contraceptives among adolescent girls (15-19 years) in Nigeria, Ethiopia and Tanzania: the Adolescents 360 quasi-experimental study protocol.

Atchison CJ, Mulhern E, Kapiga S, Nsanya MK, Crawford EE, Mussa M, Bottomley C, Hargreaves JR, Doyle AM. BMJ Open 2018;8:e021834.

PMID:29858422

PMCID:PMC5988138

DOI:10.1136/bmjopen-2018-021834

Related citation

A cluster randomized controlled trial to assess the impact on intimate partner violence of a 10-session participatory gender training curriculum delivered to women taking part in a group-based microfinance loan scheme in Tanzania (MAISHA CRT01): study protocol.

Harvey S, Lees S, Mshana G, Pilger D, Hansen C, Kapiga S, Watts C. BMC Womens Health 2018;18: 55.

PMID:29609568

PMCID:PMC5879641

DOI:10.1186/s12905-018-0546-8

Related citation

Increasing voluntary medical male circumcision uptake among adult men in Tanzania.

Wambura M, Mahler H, Grund JM, Larke N, Mshana G, Kuringe E, Plotkin M, Lija G, Makohka M, Hellar A, Terris-Prestholt F, The VMMC – Tanzania Study Group, Hayes RJ, Changalucha J, Weiss HA.

AIDS 2017; 31: 1025-1034.

PMID:28350578

PMCID:PMC5378002

DOI:10.1097/QAD.0000000000001440

Related citation

What works for human papillomavirus vaccine introduction in low and middle-income countries?

Howard N, Gallagher KE, Mounier-Jack S, Burchett HE, Griffiths UK, Kabakama S, LaMontagne DS, Watson-Jones D.

Papillomavirus Res 2017;4:22-5.

PMID:29179865

PMCID:PMC5710981

DOI:10.1016/j.pvr.2017.06.003

Related citation

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D.

PLoS One 2017;12(6):e0177773.

PMID:28575074

PMCID:PMC5456063

DOI:10.1371/journal.pone.0177773

Related citation

Why has global HPV vaccine uptake lagged? A contextual reframing of vaccine introduction. 

LaMontagne DS, Gallagher KE, Watson-Jones D.

HPV World 2017; Year 1: 10-12.

Related citation

A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples.

Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.

Sex Transm Infect 2017;93:520-9.

PMID:28377421

DOI:10.1136/sextrans-2016-053034

Related citation

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries between 2007-2016. 

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D.

Papillomavirus Res 2017;4:72-8.

PMID:29179873

PMCID:PMC5710977

DOI:10.1016/j.pvr.2017.09.001

Related citation